Altria (MO) closed the most recent trading day at $46.45, moving +1.55% from the previous trading session.
Altria's (MO) NJOY obtains authorization from the U.S. Food and Drug Administration for menthol e-vapor products.
24/7 Insights Dividend stocks can supply investors with a steady stream of passive income.
WASHINGTON — The Food and Drug Administration on Friday authorized the first menthol-flavored electronic cigarettes for adult smokers, acknowledging that vaping flavors can reduce the harms of traditional tobacco smoking.
The decision lends new credibility to vaping companies' longstanding claim that their products can help blunt the toll of smoking.
Altria distributes a generous dividend that yields 8.75% at the current share price. Its declining revenues could become a long-term threat to the sustainability of the payout.
Tobacco stocks have a bad reputation. Investors with a particular set of ethics tend to veer away from them because the companies' products are known to be detrimental to people's health.
Altria remains a profit machine, but its growth has stalled. Verizon is a top-yielding stock, and the telecom industry is showing signs of stabilizing.
In the most recent trading session, Altria (MO) closed at $44.80, indicating a +0.22% shift from the previous trading day.
Dividend growth stocks can provide reliable cash flows and drive long-term wealth for income investors. Every month we screen for dividend stocks based on safety, growth, and consistency metrics to help identify worthwhile investments. This month we have five familiar names, but one utility name we haven't touched on in over two years now, which appears to be an attractive consideration.
Diversified investors have not been rewarded so far in 2024 as the tech-heavy SPX has outperformed value strategies and the total return of defensive sectors. But Altria presents solid fundamentals with high free cash flow, steady EPS growth, and an attractive dividend yield. Altria's technical view has improved with resistance at $47-$49, support at 200-day moving average following a break of a multi-year downtrend.
Smoking causes cardiovascular diseases, even with minimal cigarette consumption. Nonetheless, its production has played a major role in America's history. Since 2005 Altria's stock performance has outperformed the S&P 500 but has stagnated since 2017. Altria's strategic shift towards e-vapor products and strong dividends make it a compelling option for income-focused investors.